Current genomic surveillance from the CDC and WHO indicates that SARS-CoV-2 continues to circulate as endemic Omicron subvariants such as BA.3.2, with detections rising modestly in early 2026 but remaining at low prevalence levels (under 1% in U.S. sequences) and without evidence of enhanced transmissibility or severity that would meet pandemic criteria. Global monitoring networks track these lineages through wastewater sampling and traveler-based sequencing, showing no novel zoonotic coronavirus emergence or exponential case growth. Historical patterns of post-2020 endemicity, combined with sustained public health infrastructure, underpin the 94.7% market-implied probability of no new coronavirus pandemic this year. Realistic shifts could arise from an undetected high-impact mutation or rare spillover event, though upcoming variant assessments in coming months would likely flag such developments early.